You are here:

Latest News

July 2017 decisions news release

Medicines for lung cancer, lymphoma and Crohn’s disease accepted for routine use by NHSScotland

The Scottish Medicines Consortium (SMC) has today (Monday 10 July) published advice accepting three new medicines for routine use by NHSScotland.

SMC Industry Engagement Event

We are pleased to announce details of the next Scottish Medicines Consortium Industry Engagement Event. This is a full day event, taking place on Wednesday 20th September 2017 at The Teacher Building in central Glasgow. Our previous event in September 2016 was very well attended with great feedback. This event is another opportunity for industry colleagues to gain a greater understanding of the SMC and its processes.

The event will run from 9.30am until 4.15pm and is priced at £350 per delegate. An agenda has been attached and is available online at the link below. The price will include a buffet lunch.

For more information and to register for a place, please sign up at https://www.eventbrite.com/e/smc-industry-engagement-event-tickets-32254908299.

We can now take credit card payments which will be processed through the secure Eventbrite portal.

June 2017 decisions news release

Four new medicines accepted for routine use by NHS Scotland

The Scottish Medicines Consortium (SMC), which reviews newly licensed medicines, has today published advice accepting four new medicines for routine use by NHS Scotland.

New guidance for Patient Group Partners taking part in SMC Committee meetings

From June 2017 we will be introducing new processes to improve how we involve patient groups in our committee meetings. 


 

Updated new product assessment form

Our new product assessment form (NPAF) for submitting companies has been changed to reflect the fact that the summary of information for patient groups (SIPs) form is now considered an essential part of a submission.

The revised form can be found on our submission guidance page

 

May 2017 decisions news release

Three new medicines for routine use by NHSScotland.

The Scottish Medicines Consortium (SMC) has today (Monday 8 May) published advice accepting three new medicines for routine use by NHS Scotland.

 

April 2017 decisions news release

Medicines for breast cancer, multiple sclerosis and leukaemia among five new treatments accepted for use in NHSScotland. 

The Scottish Medicines Consortium (SMC), which reviews newly licensed medicines, has today (Monday 10 April) published advice accepting five new medicines for routine use by NHS Scotland.

 

Medicines information leaflet for patients and public updated

An updated version of an information booklet providing information on how healthcare professionals decide what medicine is right for their patients has been published by Healthcare Improvement Scotland.

 

March 2017 decisions news release

SMC accepts treatment for follicular lymphoma 

The Scottish Medicines Consortium (SMC) has today (Monday 13 March) published advice accepting a medicine used to treat follicular lymphoma for routine use by NHS Scotland. 

 

SMC Public Partner recruitment

We are looking to recruit a new Public Partner to the Scottish Medicines Consortium committee. 

Find out more about the role.